Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500 Futures
(0.21%) 5 306.75 points
Dow Jones Futures
(0.22%) 38 877 points
Nasdaq Futures
(0.30%) 18 647 points
Oil
(-0.45%) $76.64
Gas
(4.10%) $2.69
Gold
(-0.41%) $2 336.20
Silver
(-1.03%) $30.13
Platinum
(-0.20%) $1 039.90
USD/EUR
(0.04%) $0.922
USD/NOK
(0.15%) $10.50
USD/GBP
(0.02%) $0.785
USD/RUB
(-0.42%) $90.06

Realtime updates for LIDDS AB (publ) [LIDDS.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 10:06
25% discount on Stockinvest.us - Use code: Podcast

1.09% SEK 0.139

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 10:06):

LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies...

Stats
Today's Volume 57 901.00
Average Volume 111 024
Market Cap 9.45M
EPS SEK0 ( 2024-05-30 )
Next earnings date ( SEK0 ) 2024-08-27
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -0.310
ATR14 SEK0.00900 (6.50%)

LIDDS AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

LIDDS AB (publ) Financials

Annual 2023
Revenue: SEK0
Gross Profit: SEK-475 000 (0.00 %)
EPS: SEK-0.630
FY 2023
Revenue: SEK0
Gross Profit: SEK-475 000 (0.00 %)
EPS: SEK-0.630
FY 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK0
FY 2022
Revenue: SEK1.89M
Gross Profit: SEK-36.62M (-1 939.62 %)
EPS: SEK-1.000

Financial Reports:

No articles found.

LIDDS AB (publ) Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

LIDDS AB (publ)

LIDDS AB (publ), a pharmaceutical company, develops and sells pharmaceutical products for cancer and other diseases in Sweden. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach, and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO, an immunotherapy; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies. LIDDS AB (publ) has a collaboration agreement with PharmIdea SIA to focus on anti-cancer drugs and sterile formulations. The company is based in Uppsala, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 0.85012412071228 seconds
Number of API calls: 2
Number of DB calls: 8